These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Is macular lymphocytic arteritis limited to the skin? Long-term follow-up of seven patients. Morita TCAB; Trés GFS; Criado PR An Bras Dermatol; 2020; 95(1):32-39. PubMed ID: 31889596 [TBL] [Abstract][Full Text] [Related]
44. Livedoid vasculopathy in 75 Brazilian patients in a single-center institution: Clinical, histopathological and therapy evaluation. Criado PR; Pagliari C; Morita TCAB; Marques GF; Pincelli TPH; Valente NYS; Garcia MSC; de Carvalho JF; Abdalla BMZ; Sotto MN Dermatol Ther; 2021 Mar; 34(2):e14810. PubMed ID: 33496999 [TBL] [Abstract][Full Text] [Related]
45. Cutaneous polyarteritis nodosa sine nodosa. Merman E; Rosen C; Ghazarian D; Al Habeeb A; Siddha S J Cutan Med Surg; 2014 Nov; 18(6):420-3. PubMed ID: 25348764 [TBL] [Abstract][Full Text] [Related]
46. Cutaneous manifestations of antiphospholipid antibody syndrome. Weinstein S; Piette W Hematol Oncol Clin North Am; 2008 Feb; 22(1):67-77, vi. PubMed ID: 18207066 [TBL] [Abstract][Full Text] [Related]
47. Retiform non-blanchable purpuric plaques in a patient with systemic lupus erythematosus. Grinnell M; Bath A; DiMaio D; Hultgren T; Hearth-Holmes M Lupus; 2019 Jul; 28(8):1013-1016. PubMed ID: 31126212 [TBL] [Abstract][Full Text] [Related]
48. Classification of Sneddon's syndrome. Schellong SM; Weissenborn K; Niedermeyer J; Wollenhaupt J; Sosada M; Ehrenheim C; Lubach D Vasa; 1997 Aug; 26(3):215-21. PubMed ID: 9286155 [TBL] [Abstract][Full Text] [Related]
49. Livedo reticularis and cerebrovascular accidents. Quimby SR; Perry HO J Am Acad Dermatol; 1980 Oct; 3(4):377-83. PubMed ID: 6107309 [TBL] [Abstract][Full Text] [Related]
51. Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients. Francès C; Papo T; Wechsler B; Laporte JL; Biousse V; Piette JC Medicine (Baltimore); 1999 Jul; 78(4):209-19. PubMed ID: 10424203 [TBL] [Abstract][Full Text] [Related]
52. Livedo racemosa associated with central venous catheter use in a newborn. Barsan Kaya T; Kaya Erdoğan H; Güneş D; Aydemir Ö Pediatr Dermatol; 2023 Jan; 40(1):148-150. PubMed ID: 35859318 [TBL] [Abstract][Full Text] [Related]
53. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant]. Kalashnikova LA; Prudnikova LZ; Nasonov EP Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):104-7. PubMed ID: 2175072 [TBL] [Abstract][Full Text] [Related]
54. Cutaneous manifestations of antiphospholipid syndrome. Gomez-Flores M; Herrera-Argaez G; Vazquez-Martinez O; Herz-Ruelas M; Ocampo-Candiani J; Villarreal-Martinez A; Galarza-Delgado DA; Hernandez-Galarza I; Chavez-Alvarez S Lupus; 2021 Apr; 30(4):541-548. PubMed ID: 33583236 [TBL] [Abstract][Full Text] [Related]
55. Livedo racemosa, a cutaneous sign of decompression sickness. Valentin J; Lahuna C; Amazan E; Olivier N Int J Dermatol; 2023 Aug; 62(8):1073-1075. PubMed ID: 37042416 [No Abstract] [Full Text] [Related]
56. Study of antiphospholipid antibodies in a patient with Sneddon's syndrome and her family. Lousa M; Sastre JL; Cancelas JA; Gobernado JM; Pardo A Stroke; 1994 May; 25(5):1071-4. PubMed ID: 8165682 [TBL] [Abstract][Full Text] [Related]